BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1570410)

  • 1. Incorporation of 5-fluorouracil into rat liver tumor and normal tissues and the liver nucleotide profile after administration by the hepatic artery during portal venous branch ligation.
    Jakobsson B; Roos G; el Hag IA; Jönsson PE; Stenram U
    Res Exp Med (Berl); 1992; 192(1):13-21. PubMed ID: 1570410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incorporation of 5-fluorouracil into rat liver tumor and normal tissues after administration by the hepatic artery during temporary portal vein clamping.
    el Hag IA; Jakobsson B; Jönsson PE; Stenram U
    Res Exp Med (Berl); 1990; 190(3):183-92. PubMed ID: 1695018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of 5-fluorouracil into hepatoma and normal tissue RNA at protein depletion in the rat.
    Roos G; Stenram U
    J Surg Oncol; 1997 Jul; 65(3):155-8. PubMed ID: 9236922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between the incorporation of 5-fluorouracil into liver carcinoma and normal tissue RNA at hepatic arterial administration in the rat is altered by overnight starvation.
    Roos G; Stenram U
    J Surg Oncol; 1993 Aug; 53(4):231-4. PubMed ID: 7688058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon and the incorporation of 5-fluorouracil into RNA of normal tissues and a secondary liver carcinoma in rat.
    Roos G; Stenram U
    Anticancer Res; 1994; 14(2A):379-82. PubMed ID: 7517119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dosage and infusion time on the incorporation of 5-fluorouracil into DNA and RNA of normal tissues and an adenocarcinoma transplanted to rat liver.
    Erichsen C; Christensson PI; Jacobsson B; Jönsson PE; Stenram U
    J Surg Oncol; 1988 Jul; 38(3):155-9. PubMed ID: 2455851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil incorporation into RNA of a rat liver adenocarcinoma after hepatic artery injection together with degradable starch microspheres.
    Teder H; Erichsen C; Christensson PI; Jönsson PE; Stenram U
    Cancer Drug Deliv; 1987; 4(3):169-76. PubMed ID: 2453264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma.
    Jakobsson B; el Hag IA; Erichsen C; Christensson PI; Jönsson PE; Stenram U
    Anticancer Res; 1989; 9(2):285-90. PubMed ID: 2751255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hepatic artery ligation on the incorporation of 3H-orotic acid into an adenocarcinoma transplanted to rat liver.
    Erichsen C; Christensson PI; Jönsson PE; Stenram U
    Eur J Surg Oncol; 1986 Jun; 12(2):181-6. PubMed ID: 2423375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA labelling with 3H-orotic acid and 3H-fluorouracil of rat liver tumour following transient hepatic arterial ischaemia.
    Mack P; Tranberg KG; Strenram U; Jeppsson B; Widlus D; Bengmark S
    Eur J Surg Oncol; 1988 Dec; 14(6):669-75. PubMed ID: 3192004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
    Zheng JL; Liang LJ; Hu WJ; Shen SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of 5-fluorouracil into RNA of normal tissues and an adenocarcinoma in protein-deprived rats.
    el Hag IA; Jakobsson B; Erichsen C; Christensson PI; Jönsson PE; Stenram U
    In Vivo; 1987; 1(4):215-20. PubMed ID: 2485132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
    el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
    In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of portal vein branch plus heterochronous hepatic artery branch ligation on liver regeneration (experimental study).
    Essawy MM; Nafeh AI; Ezzat HM; Elsebae MM; Marei SA; Salama AF; Badawy AA
    J Egypt Soc Parasitol; 2007 Aug; 37(2):557-70. PubMed ID: 17985588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of portal branch ligation on the outcome of repeat dearterializations of an experimental liver tumor in the rat.
    Wang LQ; Persson BG; Stenram U; Bengmark S
    J Surg Oncol; 1994 Apr; 55(4):229-34. PubMed ID: 7512673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial infusion (HAI) chemotherapy proves to be advantageous in the treatment of experimental liver tumors.
    Schlag P; Dörsam J; Aguiar JL; Bartkowski R; Berger M
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1013-8. PubMed ID: 3409939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
    Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
    Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic adenine nucleotides and DNA synthesis during the regenerative and atrophic process of the liver lobes after selective portal vein ligation.
    Kameoka N; Chijiiwa K; Kozaki N; Makino I; Naito T; Tanaka M
    Eur Surg Res; 1996; 28(3):212-21. PubMed ID: 8738531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo comparative study of the pharmacokinetics of chemotherapeutic agents infused via hepatic artery or portal vein against hepatic metastases. DRC Group].
    Naomoto Y; Gochi A; Hizuta A; Iwagaki H; Matsuno T; Hamazaki K; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1555-8. PubMed ID: 8373217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of 5-fluorouracil metabolism by thymidine. In vivo and in vitro studies on RNA-directed effects in rat liver and hepatoma.
    Engelbrecht C; Ljungquist I; Lewan L; Yngner T
    Biochem Pharmacol; 1984 Mar; 33(5):745-50. PubMed ID: 6201174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.